Author Information
Angharad Grace Davis is a distinguished researcher affiliated with several renowned institutions, including the Francis Crick Institute in London, UK, the School of Life and Medical Sciences at University College London, and the Wellcome Centre for Infectious Diseases Research in Africa at the University of Cape Town, South Africa. Her research primarily focuses on infectious diseases, with a particular emphasis on tuberculous meningitis and related neurological manifestations.Research Contributions
Angharad Grace Davis has made significant contributions to the field of infectious diseases, particularly in understanding and managing tuberculous meningitis. In 2021 alone, she has authored multiple papers exploring various aspects such as the use of aspirin in treating tuberculous meningitis, plasma pharmacokinetics of high-dose rifampicin, and the impact of communicable and non-communicable co-morbidities on COVID-19 in regions with high HIV-1 and tuberculosis prevalence. Her work also includes developing strategies for diagnosing and managing meningitis in HIV-infected adults in resource-limited settings and investigating host-directed therapies for tuberculous meningitis.Aliases
Angharad Grace Davis has published under several aliases, which include A. Davis, Angharad Davis, Angharad G. Davis, Angharad-grace Davis, and Angharad G Davis. Despite the variations, these names all refer to the same author and researcher.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
381 |
| H-Index |
10 |
| Total Paper Count |
34 |
